Stockreport

Revolution Medicines to Participate in Goldman Sachs 45th Annual Global Healthcare Conference

Revolution Medicines, Inc.  (RVMD) 
PDF REDWOOD CITY, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for [Read more]